Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-19T04:36:28.187Z Has data issue: false hasContentIssue false
  • English
  • Français

The Use of Higher-Dose Antipsychotic Medication

Comment on the Royal College of Psychiatrists' consensus statement

Published online by Cambridge University Press:  02 January 2018

John M. Kane
John M. Kane*
Affiliation:
Department of Psychiatry, Hillside Hospital, Glen Oaks, NY 11004, USA
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
The British Journal of Psychiatry , Volume 164 , Issue 4 , April 1994 , pp. 431 - 432
Copyright
Copyright © 1994 The Royal College of Psychiatrists 

References

Barnes, T. R. E. (1992) Neuromuscular effects of neuroleptics: akathisia. In Adverse Effects of Psychotropic Drugs (eds Kane, J. M. & Lieberman, J. A.), pp. 201–217. New York: Guilford Press.Google Scholar
Christison, G. W., Kirsch, D. G. & Wyatt, R. I. (1991) When symptoms persist: choosing among alternative somatic treatments for schizophrenia. Schizophrenia Bulletin, 17, 217–245.Google Scholar
Donlon, P. T., Meadow, A., Tupin, J. P., et al (1978) High versus standard dosage fluphenazine HCl in acute schizophrenia. Journal of Clinical Psychiatry, 39, 800–804.Google Scholar
Donlon, P. T., Hopkin, J. T., Tupin, J. P., et al (1980) Haloperidol for acute schizophrenic patients: an evaluation of three oral regimens. Archives of General Psychiatry, 37, 691–695.Google Scholar
Ericksen, S. E., Hurt, S. W., Chang, S., et al (1978) Haloperidol dose, plasma levels, and clinical response. A double-blind study. Psychopharmacology Bulletin, 14, 15–16.Google Scholar
Kinon, B. S., Kane, J. M., Johns, J. C., et al (1993) Treatment of neuroleptic resistant schizophrenic relapse. Psychopharmacology Bulletin, 29, 309–314.Google Scholar
Klein, D. F. & Davis, J. M. (1969) Diagnosis and Drug Treatment of Psychiatric Disorders, p. 55. Baltimore: Williams and Wilkins.Google Scholar
Levinson, D. F., Simpson, G. M., Sing, H., et al (1990) Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment. Archives of General Psychiatry, 47, 761–768.CrossRefGoogle ScholarPubMed
Neborsky, R., Janowsky, D., Munson, E., et al (1981) Rapid treatment of acute psychotic symptoms with high and low dose haloperidol. Archives of General Psychiatry, 38, 195–199.Google Scholar
Reardon, G. T., Rifkin, A., Schwarz, A., et al (1989) Changing pattern of neuroleptic dosage over a decade. American Journal of Psychiatry, 146, 726–729.Google Scholar
Rifkin, A., Doddi, S., Karagi, B., et al (1991) Dosage of haloperidol for schizophrenia. Archives of General Psychiatry, 48, 166–170.CrossRefGoogle ScholarPubMed
Van Putten, T., Marder, S. R. & Mintz, J. (1990) A controlled dose comparison of haloperidol in newly admitted schizophrenic patients. Archives of General Psychiatry, 47, 754–758.Google Scholar
Volavka, J., Cooper, T., Czobor, P., et al (1992) Haloperidol blood levels and clinical effects. Archives of General Psychiatry, 49, 354–361.Google Scholar
Wijsenbeck, H., Steiner, M. & Goldberg, S. C. (1974) Trifluoperazine: a comparison between regular and high doses. Psychopharmacologia, 36, 147–150.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.